State of Wyoming’s China SXT Pharmaceuticals SXTC Stock Holding History

State of Wyoming’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$142	–	2081
2025 Q3	$142	Buy	+1	New	+$247	﹤0.01%	1811

Other funds holding SXTC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wyoming's SXTC Position: Q4 2025 in Review

State of Wyoming sold out of China SXT Pharmaceuticals (SXTC) in Q4 2025, closing a stake of 1 share — an estimated $142 sold.

State of Wyoming first reported a position in SXTC in Q3 2025 and held it in 1 quarter. The position peaked at $142 in Q3 2025. 8 funds tracked by Wall St. Rank hold SXTC as of Q4 2025.

State of Wyoming reported no remaining China SXT Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
State of Wyoming sold 1 China SXT Pharmaceuticals share in Q4 2025, an estimated $142.
State of Wyoming first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 1 quarter.
State of Wyoming's China SXT Pharmaceuticals position peaked at $142 in Q3 2025.
8 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q4 2025.

Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.